Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
Abstract In recent years, the development of targeted therapies for tumors with KRAS mutations has progressed rapidly, rendering the notion of KRAS as “undruggable” outdated. However, targeted therapies for KRAS mutations still face numerous challenges, including resistance, efficacy concerns, toxic...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-07-01
|
| Серія: | Journal of Experimental & Clinical Cancer Research |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13046-025-03444-1 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|